Digital Health APAC

APAC Femtech Market Analysis, 2024–2034

Updated Reviewed by Vidhi Upadhyay

APAC Femtech Market Industry Trends and Forecast to 2034: Segmented by (Type, Product, End User, Region) - Growth, Market Size, Future Prospects & Competitive Analysis, 2024-2034

Overview

Market Dashboard

APAC · 2024–2034 · placeholder estimates

Values shown here are placeholder estimates, not researched figures. Researched 2024 historical, 2025 base-year and 2026–2034 forecast values are prepared with the full report.

Estimate 2024 $6.89 Bn Placeholder estimate
Estimate 2025 $7.96 Bn 21.9% of the global market
Projected 2034 $29.35 Bn 268.7% Adds $21.39 Bn over 9 forecast years
CAGR 2025–2034 15.6% Faster than 44% of 100 Digital Health markets here
Key players 6 Companies profiled
  • APAC is 21.88% of the global market.
  • Among regions, the largest is North America at $15.77 Bn.
  • Fastest growing: Africa at 15.8% a year.
  • APAC ranks 2nd of 6 by size among regions.

Market size projection

APAC

Source: Acuitas Health Analytics. Full methods, sources and usage terms come with report purchase.

Value added each year

$21.39 Bn total, 2026–2034

Year-by-year market size, 2024–2034
Femtech Market market size by year, APAC
YearMarket sizeChange that yearSince 2025
2024 (estimate) $6.89 Bn — —
2025 (base) $7.96 Bn +$1.07 Bn —
2026 (forecast) $9.20 Bn +$1.24 Bn +15.6%
2027 (forecast) $10.64 Bn +$1.44 Bn +33.6%
2028 (forecast) $12.30 Bn +$1.66 Bn +54.5%
2029 (forecast) $14.22 Bn +$1.92 Bn +78.6%
2030 (forecast) $16.43 Bn +$2.22 Bn +106.4%
2031 (forecast) $19.00 Bn +$2.56 Bn +138.6%
2032 (forecast) $21.96 Bn +$2.96 Bn +175.9%
2033 (forecast) $25.39 Bn +$3.43 Bn +218.9%
2034 (forecast) $29.35 Bn +$3.96 Bn +268.7%

Placeholder estimates. Each year is projected from our earlier market estimate and its CAGR. Researched values come with the full report.

Report snapshot

APAC Femtech Market Analysis at a glance
Market size, 2025$7.96 Bn placeholder estimate
Forecast, 2034$29.35 Bn placeholder estimate
Growth (CAGR), 2025–203415.6% placeholder estimate
Years2024 historical · 2025 base year · 2026–2034 forecast
SegmentsType, product and end user (see all)
Key playersFlo Health, Clue (BioWink), Maven Clinic, Elvie (Chiaro), Natural Cycles and 1 more (see all)
FormatsPDF, PPTX, XLSX

Sizes and growth here are placeholder estimates, not researched figures. Researched figures come with the full report.

The APAC Femtech Market Analysis Executive Summary

Femtech covers apps, devices and services built for women's health, from period tracking to fertility, pregnancy, menopause and pelvic health.

Key segments of the femtech market include type (Period and Fertility Tracking, Pregnancy and Nursing Care and Pelvic Health) and product (Apps, Wearables and Connected Devices).

Bar chart: Asia Pacific Femtech market size, 2024–2034, placeholder estimates. $6.89 Bn in 2024, $7.96 Bn in 2025 and $29.35 Bn in 2034, 15.6% CAGR.
Asia Pacific Femtech market size, 2024–2034. Placeholder estimates; researched figures come with the full report. Source: Acuitas Health Analytics.

APAC Femtech Market Dynamics

Market Growth Drivers

Greater awareness of women's health needs, more funding for female-focused research, later pregnancies and an ageing female population are driving the femtech market. New products designed around women's biology and digital care are improving access.

Opportunity

Femtech, personalised care and new treatments for under-served conditions open strong growth for the femtech market, especially as employers and payers add women's health benefits.

Market Restraints

Under-diagnosis, stigma around some conditions, limited insurance coverage and a long history of under-research in women's health hold back the femtech market.

Competitive Landscape for Femtech Market in APAC

The femtech market is moderately concentrated. Leading companies compete on product innovation, clinical evidence, pricing and geographic reach, and use partnerships and acquisitions to expand their portfolios.

Key Players

Healthcare Policies and Regulatory Landscape for Femtech Market in APAC

Femtech in APAC: rules and payment

In some of the countries we cover here, rules for health software come from TGA (Australia)⁠[1], NMPA (China)⁠[2] and PMDA (Japan)⁠[3]. How care is paid for in some of these countries: Medicare and the PBS (Australia)⁠[4], basic medical insurance (China)⁠[5], the Hospital Authority (Hong Kong)⁠[6], Ayushman Bharat PM-JAY (India)⁠[7], public health insurance (Japan)⁠[8], subsidised public care (Malaysia)⁠[9], Pharmac (New Zealand)⁠[10], PhilHealth (Philippines)⁠[11], MediShield Life (Singapore)⁠[12] and the Universal Coverage Scheme (Thailand)⁠[13].

[1] Therapeutic Goods Administration. Checked 14 Nov 2026.

[2] National Medical Products Administration. Checked 14 Nov 2026.

[3] Pharmaceuticals and Medical Devices Agency. Checked 14 Nov 2026.

[4] Pharmaceutical Benefits Scheme. Checked 14 Nov 2026.

[5] National Healthcare Security Administration. Checked 14 Nov 2026.

[6] Hospital Authority. Checked 14 Nov 2026.

[7] National Health Authority (PM-JAY). Checked 14 Nov 2026.

[8] Ministry of Health, Labour and Welfare. Checked 14 Nov 2026.

[9] Ministry of Health Malaysia. Checked 14 Nov 2026.

[10] Pharmac. Checked 14 Nov 2026.

[11] PhilHealth. Checked 14 Nov 2026.

[12] CPF Board, MediShield Life. Checked 14 Nov 2026.

[13] National Health Security Office. Checked 14 Nov 2026.

Policy changes and Reimbursement scenario

Rules on software as a medical device, data privacy (such as HIPAA and GDPR) and telehealth reimbursement shape the femtech market. Government digital health programs in APAC are speeding up adoption.

Beyond the market numbers

Research, trials and patients

What doctors and scientists are doing in Femtech right now, from free public sources.

Sources: PubMed (US National Library of Medicine), ClinicalTrials.gov. Fetched 12 Nov 2026. Papers and trials are found by search words, so the counts are a guide. Titles only; read each paper at its source.

Public data, with sources

Femtech in context

Free data on this topic

Quick answers

Frequently asked questions

How big is the Femtech market in Asia Pacific?
Placeholder estimate: about $7.96 Bn in 2025, rising to about $29.35 Bn by 2034. These are early estimates, not researched figures; the researched values come with the full report.
How fast is the Femtech market in Asia Pacific growing?
Placeholder estimate: about 15.6% a year (CAGR, 2025–2034). The researched growth rate comes with the full report.
What segments does the Femtech market report cover?
The report splits the market by type (Period and Fertility Tracking, Pregnancy and Nursing Care, Pelvic Health, Menopause Care and more), product (Apps, Wearables, Connected Devices, Services) and end user (Healthcare Providers, Patients, Payers, Pharmaceutical Companies).
Who are the key players in the Femtech market?
Key players include Flo Health, Clue (BioWink), Maven Clinic, Elvie (Chiaro), Natural Cycles and Oura.
What is driving the Femtech market?
Greater awareness of women's health needs, more funding for female-focused research, later pregnancies and an ageing female population are driving the femtech market. New products designed around women's biology and digital care are improving access.
How much research is published on Femtech?
PubMed lists 68 papers on Femtech added since January 2021, worldwide. Source: PubMed, Papers added since 1 January 2021 matching this market. Retrieved 12 Nov 2026.
Back to Catalogue

Related Digital Health reports in APAC

See all

Related on women's health and digital health

See the topic